Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Obesity

• Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes
• Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
• A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Participants Who Are Obesity or Overweight
• A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
• Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
• A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
• Ketodex Versus Opioid Based Anesthesia in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy.
• Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
• A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
• Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. A Randomized Controlled Trial
• Asiaticoside for Treating Overweight/Obesity
• Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity
• A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects
• A Trial of HRS-5817 in Obese Participants
• Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.
• A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity
• A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
• A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants
• Efficacy and Safety of ZT006 in Overweight and Obese Participants
• A Phase 3 Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
• Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
• Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
• Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
• Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
• A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy
• Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
• Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
• Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants
• A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
• Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
• Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
• Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)
• A SAD Study of HM17321 in Healthy Adult Participants
• The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
• Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure
• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
• Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
• Truway Diagnostic Tools in Primary Care
• A Phase 2 Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
• Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
• Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants
• A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
• A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
• Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
• UBT251 Injection Phase II Study (Overweight or Obesity)
• Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure
• A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
• A Study of IBI3032 in Chinese Participants With Overweight or Obesity
• Aleniglipron Phase 2 Body Composition Study
• Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects
• Randomized Controlled Trial Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
• A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity
• GLP-1R Actions on Muscle and the Skeleton
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
• Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108
• A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
• Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy) in Adult Obese or Overweight Subjects
• Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects
• Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
• A Study of XW003 Injection in Chinese Adolescents With Obesity
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
• Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
• A Research Study to Evaluate BLX-0871 in Healthy Adults
• A Research Study to Evaluate BLX-7006 in Healthy Adults
• A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity
• UBT251 Injection Phase II Clinical Study (CKD)
• Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
• Study Effects of Preoperative Modafinil on Recovery Profile of Morbidly Obese Patients Scheduled for Bariatric Surgery if it Can Enhance Recovery From Anesthesia
• PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder
• A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.
• The Study of [14C] GZR18
• The Efficacy and Safety of Efsubaglutide Alfa in Overweight/ObesitySPARKLE
• Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight
• Opioid-Free Versus Opioid-Based Anesthesia in Bariatric
• A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During, and Post-semaglutide Therapy
• A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity
• Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery
• Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
• Effect of Ketone Esters on Liver Fat Content and Metabolic Function
• Tirzepatide Use in People With Obesity and Type 1 Diabetes
• Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
• Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
• A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
• Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
• DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Nave People Living With HIV and Overweight or Obesity
• A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
• Tirzepatide in Obesity-Driven Endometrial Cancer
• A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects
• A Study of HS-20094 in Overweight or Obese Participants
• Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
• This is an Open-label, Non-randomized Study to Assess the Pharmacokinetics (PK) of VCT220 in Healthy Volunteers When Administered With Rifampin or Itraconazole
• Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
• A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
• Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
• Exploring a Natural Solution for Childhood Obesity
• A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
• Metabolic Surgery for Atrial Fibrillation Elimination
• Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
• A Phase II Study of ZT002 Injection With Subjects With Overweight or Obesity
• This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/Overweight
• A Study to Investigate the Effect of AZD6234 and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
• A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants
• A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
• The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
• Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
• A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities
• A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight
• Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
• A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations
• Tirzepatide for Alcohol Use Disorder
• A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
• A Trial With EMP16 in Preparation for Late Phase Studies
• Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor
• Protein Supplementation Intervention on Body Weight
• Probiotic Intervention on Body Weight
• A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus
• RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
• Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity
• A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants
• A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity
• A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
• A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight
• A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
• Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women
• The Efficacy and Safety of Puerarin in Obesity Treatment
• A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
• A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
• Lactate and Glycerol Contribution to Gluconeogenesis
• A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects
• Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women
• Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity
• Efficacy of Triticum Aestivum Over Vascular Function in Mexican Obese Patients
• A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants
• A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
• A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
• A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
• A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity
• A Research Study of VCT220 in Adult Chinese Participants With Obesity
• A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function
• A Study to Evaluate MWN109 Tablets in Healthy Adult Participants
• Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes Mellitus
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
• Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
• Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
• A Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
• A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI28 kg/m2
• A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function
• Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
• A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
• The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
• A Study of BGM0504 in Overweight or Obese Participants
• Efficacy and Safety of Tirzepatide for Weight Management
• Hepatoprotective Measures for Children at High Risk of NAFLD
• A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight
• A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
• A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
• A Study of BGM0504 in Participants With Obesity
• Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity
• Semaglutide Treatment in Type 1 Diabetes
• A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity
• A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
• Tirzepatide in PWS, HO and GNSO
• Atomoxetine in Melanocortin Obesity Syndrome
• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
• A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM
• Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
• Effect of Tirzepatide on Brown Adipose Tissue in Obesity
• Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight
• An Early Phase Study of RT-114
• Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
• Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults
• Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions
• Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
• A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
• A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone
• GLP-1s to Enhance Lasting Optimal Weight
• A Study to Evaluate MWN109 Injection in Healthy Subjects
• A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
• Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
• Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
• A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
• Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
• JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
• Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist
• Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
• A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes
• The Effect of a Mediterranean Intermittent Fasting Diet Compared to Weight-reducing Medication on Liver Fibrosis in People With Type 2 Diabetes and Overweight (MEDFAST-study)
• A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
• A Phase 1 Study of WVE-007 in Adults Living with Overweight or Obesity
• A Study of HS-20094 in Chinese Adults with Overweight or Obesity
• A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
• Perioperative Music in Obese Patients Under Spinal Anesthesia
• Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
• The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
• Role of KATP Channel Loss in Type 2 Diabetes
• Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
• Semaglutide's Weight Loss Effects in Obesity
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
• A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing
• A Study of a Novel Precision Medicine Approach for Obesity
• Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
• Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity
• A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
• Bariatric Surgery vs. Semaglutide vs. Tirzepatide
• TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
• Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
• The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution
• Knee Injections for Obese Patients With Knee Arthritis
• Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
• A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
• Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity
• A Single-center Study of Setmelanotide in Patients With Prader-Willi Syndrome
• Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
• Treating Toddler Obesity by Treating the Parent/Caregiver Obesity With Weight Loss Medications
• Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects
• Assessment of Pulmonary Function in Relation to the Anesthetic Used in Patients Undergoing Bariatric Surgery
• A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
• Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
• A Study of a Weight Loss Intervention in People With Endometrial Cancer
• A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
• Tirzepatide for Obesity and Meth Use Disorder
• Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
• Liraglutide Treatment in Obese Infertile PCOS Women
• Total-body Glucose Utilization in Obesity
• A Clinical Study Comparing Semaglutide Injection and Wegovy for Weight Management in Obese Subjects
• Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery
• A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity
• Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
• Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss
• Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
• A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
• 2024 Tirzepatide-Bariatric Surgery
• A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity
• A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
• Hemodynamics Stability During Opioid Free Anesthesia for Patients with Obesity
• Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects
• Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects
• A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults with Obesity or Overweight
• Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients
• A Study of BGM0504 Injection in Participants with Obesity or Overweight
• Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome
• A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus
• A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity
• Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus
• Jockey Club Precision Prevention Programme on Young Onset Diabetes
• A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity
• Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity
• Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
• Palmitic Acid and Human Microvascular Function
• A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
• A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
• Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
• A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
• Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF
• Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
• A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
• A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
• A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine
• The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome
• Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
• Phase Ia Clinical Study of HDM1005 Injection
• Phase Ib Clinical Study of HDM1005 Injection
• A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy
• A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
• A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects
• Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects
• Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet
• Tailoring Obesity Treatment Trial
• Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
• Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus
• CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes
• The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
• A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
• Diazoxide Suppression Test P&F Study
• A Study of LY3537031 in Overweight, Obese, and Healthy Participants
• A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
• A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
• Vancomycin Dose Optimization in Obesity
• Study of the Efficacy and Safety of Nicotinamide in Patients with Diabetes Mellitus Type 2 and Liver Fibrosis (NICOFIB)
• Open-Label Extension Study of Setmelanotide
• A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity
• Graded Insulin Suppression Test P&F
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
• A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
• Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
• Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
• A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
• Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
• STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
• A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population
• A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity
• A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese
• A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes
• A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
• Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition
• Laparoscopic Transversus Abdominis Plane Block Versus Erector Spinae Plane Block in Bariatric Surgery
• A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
• A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function
• Human Models of Selective Insulin Resistance: Pancreatic Clamp
• A Study of LY3532226 in Participants With Obesity
• Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake
• A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants
• A Phase I Study of GZR18 Injection in Healthy Subjects
• A Phase I Study of GZR18 Injection in Obese/Overweight Subjects
• A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight
• GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
• A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men
• A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects
• Mechanisms of Semaglutide Therapy in Heart Failure Patients
• Comorbid Obesity and Depression With an Anti-inflammatory Medication
• The Food Effect on Pharmacokinetics of DA-302168S
• Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets
• Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
• A Study of CT-388 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
• One-Year Study of S1B-509 vs Placebo for Weight Loss
• To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome
• Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
• Effect of Psiguavin for Obesity Treatment (PSIGUAVIN)
• Investigation of Optimal Dosage Regimen for HRS9531 Tablets in Healthy Subjects
• Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
• Effect of Triticum Aestivum vs Placebo on Metabolic Profile Components and Insulin Sensitivity in Patients With Obesity
• A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
• Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
• Effect of Triticum Aestivum on Appetite, Ghrelin, Leptin, Adiponectin Hormonal Axis in Patients With Obesity
• Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
• A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body
• the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human
• The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity
• Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
• A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.
• A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
• A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes
• The Effects of Semaglutide on Body Composition and Performance in Military Personnel
• A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
• Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
• A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
• LIROH - Liraglutide for Obesity in HIV
• A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects
• Effect of Nicorandil in Type 2 Diabetic Obese Patients
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
• A Phase 1b Study to Evaluate the Safety of XEN-101
• Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
• Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
• Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
• Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
• To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
• Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
• Regional Lipolysis Insulin Regulation
• GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
• The Effect of Weekly Semaglutide Treatment on Energy Expenditure
• A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
• GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
• Fibrosis Lessens After Metabolic Surgery
• A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
• A Study of ZT002 Injection in Participants With Overweight or Obesity
• Human Models of Selective Insulin Resistance: Alpelisib, Part I
• A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight
• A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
• Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study
• Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study
• A Study of LY3841136 in Overweight and Obese Participants
• Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
• The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
• A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
• VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
• A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
• A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
• A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
• A Study of LY3841136 in Japanese Participants With Obesity or Overweight
• A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
• HRS9531 Controls Weight Regain in Obese Subjects
• Semaglutide 2.4mg for Low Responders After Bariatric Surgery
• Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
• The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty
• Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
• A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus
• A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities
• Metformin IN Asthma for Overweight and Obese Individuals (MINA)
• A Study of How CagriSema Works on Appetite in People With Excess Body Weight
• Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity
• Cardiometabolic Consequences of the Loss of Ovarian Function
• A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity
• A Study of GZR18 Injection in Obese/Overweight Patients
• A Study of GZR18 Injection in Chinese Obese/Overweight Patients
• A Study of RAY1225 in Participants With Obesity
• First in Human Study in Subjects With Obesity, But Otherwise Healthy
• Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .
• A Study of RM-718 in Healthy Subjects and in Patients With HO
• A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
• A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity
• Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes
• A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
• The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.
• A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
• A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
• Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
• The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals With Obesity
• A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
• Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
• A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
• A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
• Semaglutide for Post-Smoking Cessation Weight Management
• Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
• A Study of IBI362 9 mg in Chinese Adults With Obesity
• A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension
• A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
• ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
• Cannabis for Obesity Trial
• A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
• A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
• A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
• A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
• A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
• The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics
• A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
• A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
• A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity
• A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity
• A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
• A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
• The Effect of an Anti-obesity Drug, Semaglutide, As Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (dietician) with Regards to Change in Weight and Intracranial Pressure
• A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
• Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
• Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis
• The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes
• A Study of TG103 Injection in Non-diabetic Overweight or Obesity
• A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
• Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
• A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
• Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients
• Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
• Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
• A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• Study Exploring the Supportive Effect of Acarbose in Weight Management
• Effect of Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults with Obesity
• A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
• A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
• A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
• Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
• Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
• Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity
• A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
• Study of INV-202 in Patients With Obesity and Metabolic Syndrome
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)
• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
• A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
• Semaglutide and Vascular Regeneration
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
• Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients
• Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
• Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity
• A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
• A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
• Dapiglutide for the Treatment of Obesity
• The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity
• A Trial of Setmelanotide in Acquired Hypothalamic Obesity
• A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
• Dinner Time for Obesity and Prediabetes
• Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity
• Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects
• A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
• Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men With Obesity
• POSE2.0 With GLP-1 Agonist for Obesity Management
• Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
• A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
• A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight
• REDEFINE 3: A Research Study to See the Effects of CagriSema on Heart Disease in People Living With Obesity and Diseases in the Heart and Blood Vessels
• Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Participants With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
• Effect of Probiotics Among Overweight and Obese Saudi Adults
• A Study of the Effects of Oxytocin in Adults With Obesity and Binge-eating Disorder
• A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
• Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals With Obesity and NAFLD
• A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
• Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
• A Study of LY3305677 in Participants With Obesity Or Overweight
• Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
• A Study of IBI362 in Participants With Obesity or Overweight
• Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
• A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
• Young Adults With Early-onset Obesity Treated With Semaglutide
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
• Maternal and Fetal Outcome With Metformin Therapy for Obese Pregnant Women .
• Neuroimmune Mechanisms in Obesity
• Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
• A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
• ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
• Semaglutide in Adults With Type 1 Diabetes
• Arginase Inhibition in Humans With Obesity
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities
• Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients
• Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity
• microRNAs in HIV and Obesity
• Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome
• A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
• Efficacy of Oral Semaglutide in Overweight or Obesity
• Vyvanse in Children Aged 6 to 12 Years
• Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
• Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity
• A Research Study to See How Well CagriSema Helps People Losing Weight in People Who Have a Body Weight Above the Healthy Range and Type 2 Diabetes
• Obesity Treatment to Improve Diabetes
• A Study of Distal Jejunal-release Dextrose in Obese Participants
• Phase IV Study of Qsymia in Obese Patients
• A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
• Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
• A Study of TG103 Injection in Overweight or Obesity
• A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
• Efficacy and Safety of ALT-801 in the Treatment of Obesity
• A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity
• Misoprostol Dosing in BMI Greater Than 30
• Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
• A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With Obesity
• A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity
• Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
• Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery
• A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
• A Study in People With Obesity to Test the Effects of Different Doses of BI 456906 Compared With Liraglutide on Glucagon Receptor Activity in the Liver
• Long-term Effectiveness of the Antiobesity Medication Phentermine
• Body Weight Response With Disulfiram in Humans
• Phase 2b Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)
• Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
• Study to Evaluate ARD-101 in Adults With Obesity
• Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
• EMANATE: Phase 3 Study of Setmelanotide in Patients With POMC, PCSK1, LEPR, SRC1, SH2B1, or PCSK1 N221D Genetic Variants
• Latino Semaglutide Study
• Liraglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
• Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
• A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
• Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
• Effect of Sea Grapes-antioxidants Extract in Obese Men : 4 Weeks Randomized-Double Blind Controlled Trial
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
• A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
• Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity
• The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
• Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
• A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
• Pediatric Rare Genetic Causes of Obesity
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
• Mitigating the Pro-inflammatory Phenotype of Obesity
• SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot
• A Study of IBI362 in Participants With Obesity or Overweight for Weight Loss
• ERX1000 - Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity
• Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
• Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity
• A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
• A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
• Kybella for the Treatment of Flank Fat (FF)
• Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
• Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
• A Pilot Trial of Nabilone for the Treatment of Obesity
• The Possible Effects of Roflumilast on Obesity Related Disorders
• Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
• SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
• Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous Labour.
• Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
• Open-Label Study of Setmelanotide in Hypothalamic Obesity
• A 26-Week, 2-Part Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
• Meal-regulated Substrate Metabolism, Influence of Obesity and IL-6
• Pharmacotherapy for Pediatric Obesity: A Phentermine Clinical Trial
• A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
• A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
• Dose of Magnesium Sulfate Infusion in Obese
• Liraglutide for Low-responders After Bariatric Surgery
• Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity
• Obesity and Uric Acid Stones Study
• Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity
• A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY
• STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY
• Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
• Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.
• A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery
• Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance
• Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
• Dose-ranging Study of SKF7™ for Obesity
• Oxytocin for Weight Loss in Adolescents
• EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
• Brain Activation and Satiety in Children 2
• Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
• Plasmatic Concentrations of Propofol and Remifentanil in Obese and Non Obese Patients.
• Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity
• Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension
• Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome
• Cysteine-lowering Treatment With Mesna
• A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight
• Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management
• Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
• Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity
• Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
• Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
• Optimal Anesthesia for Morbidly Obese Patients
• Developing an Obesity Treatment Program in Family Medicine Clinics
• Metformin in Dengue With Obesity
• Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity
• Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression
• Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity
• Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia
• Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity
• Effect of Obesity on Proton Pump Inhibitors
• Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors
• Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity
• A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
• Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
• Pharmacokinetics of Rivaroxaban After Bariatric Surgery
• Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients
• A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
• A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults
• A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
• Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
• Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
• Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat
• Effect of Liraglutide on Microbiome in Obesity
• Erector Spina Plane Block in Laparoscopic Sleeve Gastrectomy Surgery
• Effect and Safety of TCM-FMD in Phlegm-Dampness Type Overweight/Obesity Patients(EASTAR)
• Effects of Semaglutide in HIV-Associated Lipohypertrophy
• A Study of RTA 402 in Obese Adults
• A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
• A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
• SMART Use of Medication for the Treatment of Adolescent Severe Obesity
• A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
• Effectiveness of Dapagliflozin for Weight Loss
• IL-6 Regulation of Substrate Metabolism and Influence of Obesity
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
• Homeopathy for Overweight and Obesity in Mexican Adolescents
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
• A Phase IV Safety and Efficacy of VI-0521 in Obese Adolescents
• Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-II
• Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus
• Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
• Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery
• 48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)
• A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
• STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
• Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term
• Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
• Obesity Study to Assess Induction of Labor
• A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity
• Angiotensin-(1-7) and Energy Expenditure in Human Obesity
• Multiple Ascending Dose Study of AMG 598 in Subjects With Obesity
• Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
• Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
• Metformin Effect on Brain Function in Insulin Resistant Elderly People
• Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients
• Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity
• A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
• Tocotrienols for Obesity of Postmenopausal Women
• Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
• Long Term Extension Trial of Setmelanotide
• Brain Dopamine Function in Human Obesity
• Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI-INSIGHT)
• A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants
• Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
• Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
• Angiotensin 1-7 in Obesity Hypertension
• A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
• Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control
• A Study to Test Different Doses of BI 456906 in Patients With Obesity
• Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
• Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
• Adiposity and Endothelin Receptor Function
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
• A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
• Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs
• Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
• Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
• Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
• Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
• A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
• Safety Study of LLF580 in Obese Volunteers
• Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic
• Metabolic Effects of Natriuretic Peptide Hormones
• Body Weight, Sleep, and Heart Health
• Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
• Individualized Obesity Pharmacotherapy
• The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity
• Kybella With Triamcinolone
• Reward Mechanisms in Obesity
• A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity
• Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity
• Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
• Serum Concentration of CEFOxitin Used for Antibiotic Prophylaxis in Obese Patients Undergoing BARiatric Surgery
• Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery
• Study of NGM313 in Obese Participants
• Transnasal Endoscopy in Obese Patients Are Candidates for Bariatric Surgery
• Setmelanotide for the Treatment of LEPR Deficiency Obesity
• ZIMBA: Clinical Trial in Paediatric Obesity
• BIFI-OBESE: Clinical Trial in Paediatric Obesity
• Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066
• Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient
• Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers
• Adequacy of Perioperative Cefuroxime Dosage According to the BMI
• The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
• Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity
• Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects
• Feasibility Pilot for the ReBOO-trial
• Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
• Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
• Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
• Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
• Saxenda in Obesity Services (STRIVE Study)
• First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
• Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
• Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients
• Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
• Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
• Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
• Dyslipidemia of Obesity Intervention in Teens
• Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
• Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
• Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
• Ectopic Adipose Tissue, Exercise Training and IL-6
• Setmelanotide for the Treatment of Early-Onset POMC Deficiency Obesity
• Dexmedetomidine to Treat Bariatric Surgery-associated Pain
• Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
• Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
• Intranasal Oxytocin in Hypothalamic Obesity
• A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity
• PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction
• Biology and Experience of Eating in Women With Obesity
• Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
• Pharmacokinetic Study of Primaquine in Healthy Obese Thai Adult Subjects
• Effect of Maternal Obesity on Labour Induction in Postdate Pregnancy
• Depression, Obesity and Inflammatory Markers
• The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake
• Mechanism of Decreased Iron Absorption in Obesity: Controlling Adiposity-related Inflammation
• Short- and Long-Term Effects of Antibiotics on Childhood Growth
• Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger
• Protection Against Insulin Resistance in Obesity
• A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents
• Mechanisms Underlying Predictors of Success From Obesity Surgery
• A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects
• Gut Hormones in Obesity, Nicotine and Alcohol Dependence
• Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome
• Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
• Reprometabolic Syndrome Mediates Subfertility in Obesity
• Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
• A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
• Natriuretic Peptides and Metabolic Risk in Obesity
• Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults
• The Effect of Obesity in Dexmedetomidine Metabolic Clearance
• RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
• Testosterone, Metformin, or Both, for Hypogonadism in Obese Males
• Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
• Dysregulation of FSH in Obesity: Functional and Statistical Analysis
• A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients
• Effect of Obesity on Immune Response to Pneumovax 23
• Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity
• Dopaminergic Effects on Brown Adipose Tissue
• Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
• A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age
• Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism
• Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle
• Use of Metformin in Treatment of Childhood Obesity
• Topiramate and Severe Obesity
• Effects of High-Dose Resveratrol in Non-Diabetic Obese Males
• Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients
• Safety, Tolerability and Efficacy Study of PP1420 in HV
• GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
• Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
• Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
• Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment
• Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill
• The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery
• GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
• Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
• Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
• Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children
• Increased Cefazolin During Cesarean Delivery in Obese Population
• Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity
• Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients
• Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans
• Intragastric Injections of Botox for the Treatment of Obesity
• Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age
• Investigation of the Effects of Obesity Surgery on Appetitive Behaviour
• Vascular Dysfunction in Human Obesity Hypertension
• Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity
• Randomized Controlled Trial: Induction of Labour of Obese Women With Dinoprostone or Single Balloon Catheter
• Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity
• Metabolic Effects of Betaine Supplementation
• PK/PD of High Dose Pip/Tazo in Obese Patients
• A Toolbox Approach to Obesity Treatment in Primary Care
• Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese Patients
• Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study
• Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery
• Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
• Effects of RM-493 on Energy Expenditure in Obese Individuals
• Pharmacokinetics of Dexmedetomidine in Morbid Obesity
• Topiramate in Adolescents With Severe Obesity
• Antibiotic Prophylaxis in Bariatric Surgery With Cefazolin: Concentration in Adipose Tissue
• Amlexanox for Type 2 Diabetes and Obesity
• Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
• Mediators of Abnormal Reproductive Function in Obesity (MARO)
• ER Stress in NAFLD
• Enoxaparin Dosing in Obesity
• Comparison of MAG and Fish Oil Efficacy
• Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
• Vitamin D and Omega-3 Adiposity Trial (VITAL Adiposity)
• Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
• Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue
• The Health Influences of Puberty (HIP) Study
• Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients
• Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
• Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults
• A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling
• To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
• Study of Growth Hormone and Bone in Obesity
• Evaluating the Safety and Efficacy of Euiiyin-tang on Obesity
• Females, Aging, Metabolism, and Exercise
• Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin
• Intravenous Ibuprofen for Laparoscopic Bariatric Surgery
• Effect of DPP4 Inhibition on Growth Hormone Secretion
• Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease
• Angiotensin II Blockade and Inflammation in Obesity
• Endoscopic Gastric Reduction for Weight Management
• Obesity in Children and Adolescents: Associated Risks and Early Intervention
• An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects
• The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine
• Study to Evaluate the Pharmacokinetics of Vitamin D (Cholecalciferol) in Patients Undergoing Obesity Surgery in a Deficit Situation and After Standardization
• Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue
• Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity
• Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide
• Safety and Pharmacokinetic Study of Y242 in Adult Subjects
• ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity
• Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients
• Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
• Effects of Acipimox on Mitochondrial Function in Obesity
• Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
• RYGB and the Gastric Adipose Axis
• Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia
• Obesity in HIV After Antiretroviral Therapy
• Reproductive Hormonal Alterations in Obesity
• Phenotypical Approach of the Drug Metabolizing Hormones Activity Before and After Roux-en Y-Gastric Bypass
• Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
• Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications
• The Impact of Obesity on Nonsurgical Periodontal Therapy
• Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal
• The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity
• Estrogen Sensitivity and Ovulatory Dysfunction in Obesity
• Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans
• Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers
• Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
• The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension
• Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
• Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass.
• Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations
• Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors
• Diacerein on Insulin Secretion in Diabetes
• The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
• Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients
• Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity.
• In Vivo Leptin Signaling in Humans After Acute Leptin Administration
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
• Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity
• Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity
• Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery
• Patients-Controlled Epidural Analgesia After Gastric Bypass for Morbid Obesity Using Morphine-Levobupivacaine Regimens
• Propofol in Obese Children
• Insulin Detemir in Obesity Management
• Exenatide in Extreme Pediatric Obesity
• A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects
• A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
• Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity
• Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects
• Study of Fat Malabsorption by Lipiblock Versus Xenical
• Studying the Effects of Sibutramine on Eating Behavior
• Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls
• Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations
• Effect of Weight and/or Obesity on Dapsone Drug Concentrations
• Resveratrol in Type2 Diabetes and Obesity
• Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration
• Treatment of Adiposity Related hypErTension (TARGET)
• Pathophysiology of Cardiometabolic Risk Factors in African Americans
• Peri -and Postoperative Drug Therapy Schedules for Morbidly Obese Patients
• An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
• Pharmacokinetics in Morbid Obesity After Bariatric Surgery
• The Effect of Pre-Operative Transversus Abdominis Plane (TAP) Block in the Post Operative Opioid Consumption in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study
• Rosuvastatin in Visceral Adiposity
• Effect of Weight and/or Obesity on Caspofungin Drug Concentrations
• Effects of Exenatide on Hypothalamic Obesity
• A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects
• Effect of Weight and/or Obesity on Ethambutol Drug Concentrations
• A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers
• Effects of Vitamin D Supplementation in Obesity
• Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers
• Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
• Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity
• Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients
• Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat
• Irbesartan Versus Amlodipine: The OBI Study
• Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects
• [11C]Carfentanil PET Study of GSK1521498
• Effect of Furosemide on Obesity-induced Glomerular Hyperfiltration
• Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients
• A Study of Xenical (Orlistat) in Overweight and Obese Adolescents
• The Impact of Obesity and Obesity Treatments on Breast Cancer
• Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy
• Effect of Vitamin D Supplementation on Fasting Glucose and Interleukin-10 (IL-10) in Arab Women With Impaired Fasting Glucose
• Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
• A First-Time-In-Human Study in Healthy Subjects
• Pioglitazone on Pancreatic Steatosis and Bone Health
• Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes
• Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity
• Reduced Carbohydrate Versus Fat in Obese Subjects
• A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.
• Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls
• Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
• A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)
• Incretin Effect in People With Impaired Fasting Glucose
• Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
• Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
• Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
• Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation
• Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss
• n-3 Polyunsaturated Fatty Acids in Obesity
• Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
• Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
• A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
• Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity
• The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
• Prevention of Obesity in Women Via Estradiol Regulation
• Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3
• Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
• Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
• A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes
• DZX Mediated Insulin Suppression in Obese Men
• Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
• BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management
• BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
• The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition
• Mechanisms Underlying Metabolic Syndrome in Obesity
• A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults
• Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
• Sodium Tungstate in Obesity
• Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults
• Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity
• Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions
• A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity
• A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
• Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults
• Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
• Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
• Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension
• Efficacy and Safety of THR-4109 in Obese Subjects
• Evaluation of Long Term Safety of Tesofensine in Patients With Obesity
• Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
• A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
• Mechanism of Growth Hormone Effects on Adipose Tissue
• Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)
• Craving, Binge Eating and Obesity
• High Density Lipoprotein Turnover
• Effect of Body Mass Index on the Dose of Intrathecal Hyperbaric Bupivacaine for Elective Cesarean Section
• BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
• Effect of Tesofensine on Weight Reduction in Patients With Obesity.
• Regulation of Lipoprotein Metabolism in Obese Men
• A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients
• Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)
• An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)
• "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat
• Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity
• Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men
• Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
• Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery
• Effect of Conjugated Linoleic Acid Supplement on Body Composition
• Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity
• Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
• Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)
• Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects
• Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
• A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights
• Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
• Integrating the Genetic and Metabolic Faces of Obesity
• Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
• A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity
• Obesity and Nonalcoholic Fatty Liver Disease
• A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
• The Study of Inflammation on Blood Glucose Levels in Obese People
• Fibre and Appetite Regulation Trial (FART)
• Treatment of Obesity With Vitamin D (40.000 IE Per Week for 1 Year)
• A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients
• A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity
• A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity
• A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients
• A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity
• Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
• Effectiveness of Brief Counseling for Weight Management
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity
• Glaser Obesity Study
• The Autonomic Nervous System and Obesity
• A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients
• A Comparative Study of KES524 in Patients With Obesity Disease
• Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human Obesity
• The Effect of Xenical on Weight and Risk Factors
• Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects
• Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity
• An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)
• Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
• Glaser Obesity Study
• Safety and Efficacy of APD356 in the Treatment of Obesity
• LOSS- Louisiana Obese Subjects Study
• An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
• A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
• Safety and Efficacy of APD356 in the Treatment of Obesity
• Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity
• Pediatric Hypothalamic Obesity
• Low-Dose Leptin and the Formerly-Obese
• Effects of Leptin Treatment on Weight Loss
• Obese Patients With Type 2 Diabetes
• Metformin to Treat Obesity in Children With Insulin Resistance
• Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
• Cardiovascular System in Obesity: Effect of Treatment